Henry Alba, MD
Physical Medicine & Rehabilitation · Greenfield, WINPI 1770695017
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,000 of the $1,445 with a category attached, or 69.2%. Merck accounts for 69.2% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2021 at $1,041 and has fallen 94.4% since, to $58 in 2023.
Across 24 payments — averaging $60.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$1K
- Fidia Pharma USA Inc.$90
- Lilly USA, LLC$82
- AbbVie$58
- Pacira Therapeutics, Inc.$47
- Ipsen Biopharmaceuticals, Inc$33
- plus $136 from 6 others
What the payments were for
- Consulting fees$1,00069%
- Food & beverage$44531%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 1 | $1,000 |
| Fidia Pharma USA Inc. | 5 | $90 |
| Lilly USA, LLC | 4 | $82 |
| AbbVie | 3 | $58 |
| Pacira Therapeutics, Inc. | 2 | $47 |
| Ipsen Biopharmaceuticals, Inc | 1 | $33 |
| Pfizer | 2 | $33 |
| Teva Pharmaceuticals USA, Inc. | 2 | $26 |
| Nevro Corp. | 1 | $24 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $23 |
| Lundbeck LLC | 1 | $16 |
| Vertical Pharmaceuticals, LLC | 1 | $14 |
How this compares
$1,445 in reported general payments places this provider in the 85th percentile of 207 physical medicine & rehabilitation providers in Wisconsin.
See all physical medicine & rehabilitation providers in Wisconsin →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 61 | $3,100 |
| Buprenorphine Hcl | 15 | $2,564 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 50 | $2,346 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 42 | $1,792 |
| Gabapentin | 50 | $594 |
| Ropinirole Hcl | 23 | $569 |
| Cyclobenzaprine Hcl | 58 | $415 |
| Tizanidine Hcl | 24 | $236 |
| Celecoxib | 19 | $181 |
| Zolpidem Tartrate | 21 | $139 |
| Lorazepam | 12 | $119 |
| Clonazepam | 17 | $36 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Greenfield
- Henry RoslerGreenfield$653
- Nicholas KetchumMilwaukee$573K
- Christopher CronsellMilwaukee$353K
- Karin GoodfriendMilwaukee$191K
- John McGuireMilwaukee$75K
- Erin McGonigleMilwaukee$66K
- Noelle LiskaMilwaukee$13K
- Trinh TruongMilwaukee$11K
- Bindiya ShahMilwaukee$10K
- Michelle FaullMonroe$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.